Case reports A rare case of Suppurative Bacille Calmette-Guerin (BCG) lymphadenitis

Authors

  • Dr. Pratik P Kamlik MIMER Medical College
  • Dr. Gauri Metkar MIMER Medical College
  • Dr Smita Bhide MIMER Medical College
  • Dr. Harsha Dangare MIMER Medical College
  • Dr. Mangala Nagare MIMER Medical College
  • Dr. Swapnil More MIMER Medical College
  • Dr. Rajendra Zope MIMER Medical College

Keywords:

BCG, FNAC, Lymphadenitis, Suppuration

Abstract

ABSTRACT

Title- A rare case of Suppurative Bacille Calmette-Guerin (BCG) lymphadenitis 

Dr. Pratik P Kamlik1,  Dr. Gauri Metkar2, Dr Smita Bhide3, Dr. Harsha Dangare3, Dr. Mangala Nagare4, Dr. Swapnil More5, Dr. Rajendra Zope6

Introduction:

The Bacillus Calmette Guerin (BCG) vaccine is live attenuated Mycobacterium bovis vaccine, first introduced in 1921 to prevent tuberculosis. In 1974 WHO expanded the program on Immunization so that all children should have the BCG vaccine intra-dermally.

Case History:

We are presenting a rare case of a 9 months old female child with fever, cold, and tender cervical lymphadenopathy with no past or family history of tuberculosis. Patient had acute onset cervical lymphadenopathy on the same side (ipsilateral) as that of BCG vaccination. Size of enlarged lymph node was 5 x 5 cm. On FNAC, findings were of suppurative lymphadenitis with presence of acid fast bacilli. Ipsilateral location of cervical lymphadenitis, size > 1 cm and presence of acid fast bacilli, prove it to be BCG lymphadenitis. 

Discussion: 

BCG lymphadenitis is a lesser-known condition with incidence of 0.5-100 per 1000 vaccinations. Most common presentation of BCG lymphadenitis is non-suppurative ipsilateral axillary lymphadenitis with onset between 2 weeks to 6 months of age. Hence this is a rare case of BCG lymphadenitis with unusual features like suppuration, cervical lymph node involvement, and presentation at 9 months of age.

Conclusion:

BCG lymphadenitis is a rare complication of BCG vaccination most commonly affecting axillary lymph nodes. Present case highlights the importance of keeping this entity in differential diagnosis of childhood lymphadenitis. FNAC with AFB (20%) staining helps in diagnosis and timely treatment of this condition eliminating the need of surgical excision and un-necessary antibiotic treatment.

Key words: BCG, FNAC, Lymphadenitis, Suppuration

Author Biographies

Dr. Pratik P Kamlik, MIMER Medical College

Junior Resident, Dept. of Pathology

Dr. Gauri Metkar, MIMER Medical College

Professor, Dept. of Pathology

Dr Smita Bhide, MIMER Medical College

Professor and HOD, Dept. of Pathology

Dr. Harsha Dangare, MIMER Medical College

Associate Professor, Dept. of Pathology

Dr. Mangala Nagare, MIMER Medical College

Associate Professor, Dept. of Pathology

Dr. Swapnil More, MIMER Medical College

Associate Professor, Dept. pf Pathology

Dr. Rajendra Zope, MIMER Medical College

Associate Professor, Dept. of Pathology

References

References:

Okafor CN, Rewane A, Momodu II. Bacillus Calmette Guerin. [Updated 2023 Jul 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538185/

Kaufmann SH, Lange C, Rao M, Balaji KN, Lotze M, Schito M, Zumla AI, Maeurer M. Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review. Lancet Respir Med. 2014 Apr;2(4):301-20. doi: 10.1016/S2213-2600(14)70033-5. Epub 2014 Mar 24. PMID: 24717627.

Bricks LF. Vacina BCG: via percutânea ou intradérmica? [Percutaneous or intradermal BCG vaccine?]. J Pediatr (Rio J). 2004 Mar-Apr;80(2):93-8. Portuguese. PMID: 15079177.

Lotte A., Wasz-Höckert O., Poisson N., Dumitrescu N., Verron M., Couvet E. BCG complications. Adv Tuberc Res. 1984;21:107–193. [PubMed] [Google Scholar]

Suliman O.M., Ahmed M.J., Bilal J.A. Clinical characteristics and needle aspiration management of Bacillus Calmette-Guérin lymphadenitis in children. Saudi Med J. 2015 Mar;36(3):280–285. [PMC free article] [PubMed] [Google Scholar]

Ru Sorense. Clinical presentation of tuberculosis in patient with immunodeficiency. Pediatr Infect Dis J. 1989;8:201–206. Annals of Pediatric Surgery, Vol 5, No 3, July 2009, PP 187–193. [PubMed] [Google Scholar]

Grange J.M. Complications of Bacille Calmette-Guérin (BCG) vaccination and immunotherapy and their management. Commun Dis Public Health. 1998;1:84–88. [PubMed] [Google Scholar]

Elsidig N, Alshahrani D, Alshehri M, Alzahrani M, Alhajjar S, Aljummah S, Bin Hussain I, Alshaalan M, Alzamil F, Alodyani A, Aljobair F. Bacillus Calmette-Guérin vaccine related lymphadenitis in children: Management guidelines endorsed by the Saudi Pediatric Infectious Diseases Society (SPIDS). Int J Pediatr Adolesc Med. 2015 Jun;2(2):89-95. doi: 10.1016/j.ijpam.2015.05.003. Epub 2015 May 29. PMID: 30805444; PMCID: PMC6372430.

Chan W.M., Kwan Y.W., Leung C.W. Management of Bacillus Calmette-Guérin lymphadenitis. HK J Paediat. 2011;16:85–94. (new series) [Google Scholar]

Goraya J.S., Virdi V.S. Treatment of Calmette-Guérin bacillus adenitis: a metaanalysis. Pediatr Infect Dis J. 2001 Jun;20(6):632–634. PubMed PMID: 11419511. [PubMed] [Google Scholar]

Sataynarayana S., Mathur A.D., Verma Y., Pradhan S., Bhandari M.K. Needle aspiration as a diagnostic tool and therapeutic modality in suppurative lymphadenitis following Bacillus Calmette Guerin vaccination. J Assoc Physicians India. 2002 Jun;50:788–791. PubMed PMID: 12240843. [PubMed] [Google Scholar]

Venkataraman A, Yusuff M, Liebeschuetz S, Riddell A, Prendergast AJ. Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions. Vaccine. 2015;33:5470–4. [PMC free article] [PubMed] [Google Scholar] [Ref list]

Milstien JB, Gibson JJ. Quality control of BCG vaccine by WHO: A review of factors that may influence vaccine effectiveness and safety. Bull World Health Organ. 1990;68:93–108. [PMC free article] [PubMed] [Google Scholar] [Ref list]

Norouzi S, Aghamohammadi A, Mamishi S, Rosenzweig SD, Rezaei N. Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases. J Infect. 2012;64:543–54. [PMC free article] [PubMed] [Google Scholar] [Ref list]

Bolger T, O’Connell M, Menon A, Butler K. Complications associated with the Bacille Calmette-Guérin vaccination in Ireland. Arch Dis Child. 2006;91:594–7. [PMC free article] [PubMed] [Google Scholar] [Ref list]

Riordan A, Cole T, Broomfield C. Fifteen-minute consultation: Bacillus Calmette-Guérin abscess and lymphadenitis. Arch Dis Child Educ Pract Ed. 2014;99:87–9. [PubMed] [Google Scholar] [Ref list]

Alfawaz TS, Alshehri M, Alshahrani D. BCG related complications: A single center, prospective observational study. Int J Pediatr Adolesc Med. 2015 Jun;2(2):75-78. doi: 10.1016/j.ijpam.2015.05.004. Epub 2015 Jun 11. PMID: 30805441; PMCID: PMC6372398.

Chaves_carballo E., Sanchez G.A. Regional lymphadenitis following BCG vaccination (BCGitis). Clinical based upon 25 instances among 1295 children. Clin Pediatr (Phila) 1972;11:693–697. [PubMed] [Google Scholar] [Ref list],

Ali S., Al Moudaris M. BCG lymphadenitis. Arch Dis Child. 2004;89:812. [PMC free article] [PubMed] [Google Scholar] [Ref list]

Published

2025-01-31